Zobrazeno 1 - 10 of 69 pro vyhledávání: '"Lisbeth Juhler, Andersen"'
1
Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
Autor: Claus Kristensen, Line Brøndum, Jan F. Evensen, Jens Overgaard, C. Maare, Jan Alsner, Jørgen Johansen, Brita Singers Sørensen, Jesper Grau Eriksen, Lisbeth Juhler Andersen, Hanne Primdahl
Publikováno v: Brøndum, L, Alsner, J, Sørensen, B S, Maare, C, Johansen, J, Primdahl, H, Evensen, J F, Kristensen, C A, Andersen, L J, Overgaard, J & Eriksen, J G 2018, ' Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial ', Acta Oncologica, vol. 57, no. 9, pp. 1159-1164 . https://doi.org/10.1080/0284186X.2018.1464664
Brøndum, L, Alsner, J, Sørensen, B S, Maare, C, Johansen, J, Primdahl, H, Evensen, J F, Kristensen, C A, Andersen, L J, Overgaard, J & Eriksen, J G 2018, ' Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab : results from the DAHANCA 19 trial ', Acta Oncologica, vol. 57, no. 9, pp. 1159-1164 . https://doi.org/10.1080/0284186X.2018.1464664
Purpose: To study the associations between development of moderate to severe skin rash, clinical outcome, and single nucleotide polymorphisms (SNPs) in candidate genes in head and neck cancer patients from the DAHANCA 19 trial receiving the EGFR-inhi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1e936eb750b6dde160b2d983dbcb95
Zobrazit plný text záznamu
2
DAHANCA 9 – a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)
Autor: Jan F. Evensen, Hanne Sand Hansen, Marie Overgaard, Lisbeth Juhler Andersen, Jens Overgaard, Jørgen Johansen
Publikováno v: Evensen, J, Hansen, H S, Overgaard, M, Johansen, J, Andersen, L J & Overgaard, J 2013, ' DAHANCA 9-A randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) ', The European cancer congress, Amsterdam, Netherlands, 30/09/2013 .
Evensen, J F, Sand Hansen, H, Overgaard, M, Johansen, J, Andersen, L J & Overgaard, J 2019, ' DAHANCA 9–a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) ', Acta Oncologica, vol. 58, no. 10, pp. 1502-1505 . https://doi.org/10.1080/0284186X.2019.1629012
Evensen, J F, Sand Hansen, H, Overgaard, M, Johansen, J, Andersen, L J & Overgaard, J 2019, ' DAHANCA 9-a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) ', Acta oncologica (Stockholm, Sweden), vol. 58, no. 10, pp. 1502-1505 . https://doi.org/10.1080/0284186X.2019.1629012
University of Southern Denmark
Following the DAHANCA 5 trial [1], which demonstrated the benefit of the hypoxic radiosensitizer Nimorazole, and the DAHANCA 6&7 trial, which demonstrated that accelerated fractionation added signi...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b44368a5711fa3bb678d9c76b484bb0
https://doi.org/10.1080/0284186x.2019.1629012
Zobrazit plný text záznamu
3
Subglottic squamous cell carcinoma in Denmark 1971-2015 - a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group
Autor: Louise Hill-Madsen, Elo Andersen, Jørgen Johansen, Nina Munk Lyhne, Hanne Primdahl, Lisbeth Juhler Andersen, Claus Kristensen, Jens Overgaard
Publikováno v: Hill-Madsen, L, Kristensen, C A, Andersen, E, Johansen, J, Andersen, L J, Primdahl, H, Overgaard, J & Lyhne, N M 2019, ' Subglottic squamous cell carcinoma in Denmark 1971-2015-a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group ', Acta oncologica (Stockholm, Sweden), vol. 58, no. 10, pp. 1509-1513 . https://doi.org/10.1080/0284186X.2019.1645355
Hill-Madsen, L, Kristensen, C A, Andersen, E, Johansen, J, Andersen, L J, Primdahl, H, Overgaard, J & Lyhne, N M 2019, ' Subglottic squamous cell carcinoma in Denmark 1971–2015–a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group ', Acta Oncologica, vol. 58, no. 10, pp. 1509-1513 . https://doi.org/10.1080/0284186X.2019.1645355
Cancers arising in the larynx are divided into supraglottic, glottic and subglottic tumors. Primary subglottic cancer constitutes less than 5% of all laryngeal malignancies [1–6], and are histologi...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864866deb2ff57ffd13668b0adf55777
https://pubmed.ncbi.nlm.nih.gov/31364888
Zobrazit plný text záznamu
4
Salivary duct carcinoma: a Danish national study
Autor: Christian Godballe, Hanne Primdahl, Claus A. Kristensen, Mohammad Talal Elhakim, Helle Breinholt, Lisbeth Juhler Andersen, Kristine Bjørndal
Publikováno v: Breinholt, H, Elhakim, M T, Godballe, C, Andersen, L J, Primdahl, H, Kristensen, C A & Bjørndal, K 2016, Salivary duct carcinoma : A Danish national study . in XIII Årsmøde i Dansk Selskab for Otorhinolaryngologi, Hoved-& Halskirurgi . pp. 66, DSOHH årsmøde, Nyborg, Denmark, 12/05/2016 .
Breinholt, H, Elhakim, M T, Godballe, C, Andersen, L J, Primdahl, H, Kristensen, C A & Bjørndal, K 2016, ' Salivary duct carcinoma : a Danish national study ', Journal of Oral Pathology & Medicine, vol. 45, no. 9, pp. 664-671 . https://doi.org/10.1111/jop.12426
Breinholt, H, Talal Elhakim, M, Godballe, C, Andersen, L J, Primdahl, H, Kristensen, C A & Bjørndal, K 2016, ' Salivary duct carcinoma : a Danish national study ', Journal of Oral Pathology & Medicine, vol. 45, no. 9, pp. 664–671 . https://doi.org/10.1111/jop.12426
Breinholt, H, Elhakim, M T, Godballe, C, Andersen, L J, Primdahl, H, Kristensen, C A & Bjørndal, K 2016, ' Salivary duct carcinoma: a Danish national study ', Journal of Oral Pathology & Medicine, vol. 45, no. 9, pp. 664-671 . https://doi.org/10.1111/jop.12426
BACKGROUND:To present the first national series of salivary duct carcinoma patients, including survival rates and an analysis of prognostic factors.METHODS:By merging three Danish nationwide registries that encompass an entire population, 34 patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69d1828fe6652bd764165f805c6a929
https://doi.org/10.1111/jop.12426
Zobrazit plný text záznamu
5
DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
Autor: Hanne Sand Hansen, Pernille Lassen, Camilla Molich Hoff, Cai Grau, Elo Andersen, Lisbeth Juhler Andersen, Jan Alsner, Marie Overgaard, Jørgen Johansen, Jens Overgaard, Lena Specht, Jan F. Evensen
Publikováno v: Overgaard, J, Hoff, C M, Hansen, H S, Specht, L, Overgaard, M, Lassen, P, Andersen, E, Johansen, J, Andersen, L J, Evensen, J F, Alsner, J & Grau, C 2018, ' DAHANCA 10 – Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group ', Radiotherapy and Oncology, vol. 127, no. 1, pp. 12-19 . https://doi.org/10.1016/j.radonc.2018.02.018
Overgaard, J, Hoff, C M, Hansen, H S, Specht, L, Overgaard, M, Lassen, P, Andersen, E, Johansen, J, Andersen, L J, Evensen, J F, Alsner, J & Grau, C 2018, ' DAHANCA 10-Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck : A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group ', Radiotherapy & Oncology, vol. 127, no. 1, pp. 12-19 . https://doi.org/10.1016/j.radonc.2018.02.018
Overgaard, J, Hoff, C M, Hansen, H S, Specht, L, Overgaard, M, Lassen, P, Andersen, E, Johansen, J, Andersen, L J, Evensen, J F, Alsner, J & Grau, C 2018, ' DAHANCA 10-Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group ', Radiotherapy & Oncology, vol. 127, no. 1, pp. 12-19 . https://doi.org/10.1016/j.radonc.2018.02.018
PURPOSE: To evaluate if correction of low hemoglobin (Hb) levels by means of darbepoetin alfa improves the outcomes of radiotherapy in patients with squamous cell carcinoma of the head and neck (HNSCC).PATIENTS AND METHODS: Patients eligible for prim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60a97cdedfbe703ccb69b5d37dc4d3b8
https://pubmed.ncbi.nlm.nih.gov/30414758
Zobrazit plný text záznamu
6
Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy
Autor: Hella Maria Brøgger Sand, Cai Grau, Elo Andersen, Anders Bertelsen, Jørgen B. B. Petersen, Lisbeth Juhler Andersen, Christian Rønn Hansen, Kenneth Jensen, E. Samsøe, Jørgen Johansen
Publikováno v: Hansen, C R, Johansen, J, Samsøe, E, Andersen, E, Petersen, J B B, Jensen, K, Andersen, L J, Sand, H M B, Bertelsen, A S & Grau, C 2018, Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy . in Danske Kræftforskningsdage : Abstract Book ., #24, pp. 30, Danske Kræftforskningsdage 2018, Odense, Denmark, 30/08/2018 .
Hansen, C R, Johansen, J, Samsøe, E, Andersen, E, Petersen, J B B, Jensen, K, Andersen, L J, Sand, H M B, Bertelsen, A S & Grau, C 2018, ' Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy ', Radiotherapy & Oncology, vol. 126, no. 1, pp. 43-47 . https://doi.org/10.1016/j.radonc.2017.09.019
Hansen, C R, Johansen, J, Samsøe, E, Andersen, E, Petersen, J B B, Jensen, K, Andersen, L J, Sand, H M B, Bertelsen, A S & Grau, C 2018, ' Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy ', Radiotherapy and Oncology, vol. 126, no. 1, pp. 43-47 . https://doi.org/10.1016/j.radonc.2017.09.019
BACKGROUND AND PURPOSE:Defining margins around the Gross Tumour Volume (GTV) to create a Clinical Target Volume (CTV) for head and neck cancer radiotherapy has traditionally been based on presumed knowledge of anatomical routes of spread. However, us
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63f468d64e8a343825375a60a9c0a86
https://vbn.aau.dk/da/publications/8ccf0725-de5f-4cee-8e91-08e81934c748
Zobrazit plný text záznamu
7
Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers
Autor: Anne Hostrup Brunø, Hella Maria Brøgger Sand, Lisbeth Juhler Andersen, Jesper Carl
Publikováno v: Sand, H M B, Brunø, A H, Andersen, L J & Carl, J 2015, ' Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers ', Acta Oncologica, vol. 54, no. 9, pp. 1682-1685 . https://doi.org/10.3109/0284186X.2015.1071919
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae7a8d8bf1adfb236fcec0dccc97ccc
https://doi.org/10.3109/0284186x.2015.1071919
Zobrazit plný text záznamu
8
Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial
Autor: Cai Grau, E. Samsøe, Jørgen B. B. Petersen, Lisbeth Juhler Andersen, Elo Andersen, B. Smulders, Christian Rønn Hansen, Claus A. Kristensen, Jørgen Johansen, Jens Overgaard
Publikováno v: Hansen, C R, Johansen, J, Kristensen, C A, Smulders, B, Andersen, L J, Samsøe, E, Andersen, E, Petersen, J B B, Overgaard, J & Grau, C 2015, ' Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial ', Acta Oncologica, vol. 54, no. 9, pp. 1669-73 . https://doi.org/10.3109/0284186X.2015.1063780
Hansen, C R, Johansen, J, Kristensen, C A, Smulders, B, Andersen, L J, Samsøe, E, Andersen, E, Petersen, J B B, Overgaard, J & Grau, C 2015, ' Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial ', Acta Oncologica, vol. 54, no. 9, pp. 1669-1673 . https://doi.org/10.3109/0284186X.2015.1063780
Previous studies have shown that poorly executed radiotherapy in clinical trials may potentiality obscure the benefits of a new treatment technique or drug [1] or significantly change the clinical ...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e6a365b52376b9b92e1ae0c85fbdd84
https://doi.org/10.3109/0284186x.2015.1063780
Zobrazit plný text záznamu
9
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
Autor: Pernille Lassen, Lisbeth Juhler Andersen, Elo Andersen, Jørgen Johansen, Claus Kristensen, Jan F. Evensen, Jens Overgaard, Hanne Primdahl, Jesper Grau Eriksen
Publikováno v: Lassen, P, Primdahl, H, Johansen, J, Kristensen, C A, Andersen, E, Andersen, L J, Evensen, J F, Eriksen, J G, Overgaard, J & Danish Head and Neck Cancer Group (DAHANCA) 2014, ' Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer ', Radiotherapy & Oncology, vol. 113, no. 3, pp. 310-6 . https://doi.org/10.1016/j.radonc.2014.11.032
Lassen, P, Primdahl, H, Johansen, J, Kristensen, C A, Andersen, E, Andersen, L J, Evensen, J F, Eriksen, J G, Overgaard, J & Danish Head and Neck Cancer Group (DAHANCA) 2014, ' Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer ', Radiotherapy & Oncology, vol. 113, no. 3, pp. 310-316 . https://doi.org/10.1016/j.radonc.2014.11.032
Background and purpose: HPV is found in head and neck cancer from all sites with a higher prevalence in oropharynx cancer (OPC) compared to non-OPC. HPV/p16-status has a significant impact on radiotherapy (RT) outcome in advanced OPC, but less is kno
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5127b513ca6ac09a3fbbf2377cee6c
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje